Search results for the GEO ID: GSE8057
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM198888
GPL8300
A2780_cis_IC90_pre_1 A2780 cells, exposed 2 h to cisplatin at IC90 , pre. A2780 human ovarian carcinoma cells NA
GSM198889
GPL8300
A2780_cis_IC90_pre_2 A2780 cells, exposed 2 h to cisplatin at IC90 , pre. A2780 human ovarian carcinoma cells NA
GSM198890
GPL8300
A2780_control_pre A2780 cells, control , pre. A2780 human ovarian carcinoma cells NA
GSM198891
GPL8300
A2780_oxa_IC90_pre_1 A2780 cells, exposed 2 h to oxaliplatin at IC90 , pre. A2780 human ovarian carcinoma cells NA
GSM198892
GPL8300
A2780_oxa_IC90_pre_2 A2780 cells, exposed 2 h to oxaliplatin at IC90 , pre. A2780 human ovarian carcinoma cells NA
GSM198893
GPL8300
A2780_cis_IC90_0h_1 A2780 cells, exposed 2 h to cisplatin at IC90 , 0h. A2780 human ovarian carcinoma cells NA
GSM198894
GPL8300
A2780_cis_IC90_0h_2 A2780 cells, exposed 2 h to cisplatin at IC90 , 0h. A2780 human ovarian carcinoma cells NA
GSM198895
GPL8300
A2780_cis_IC90_2h_1 A2780 cells, exposed 2 h to cisplatin at IC90 , 2h. A2780 human ovarian carcinoma cells NA
GSM198896
GPL8300
A2780_cis_IC90_2h_2 A2780 cells, exposed 2 h to cisplatin at IC90 , 2h. A2780 human ovarian carcinoma cells NA
GSM198897
GPL8300
A2780_cis_IC90_6h_1 A2780 cells, exposed 2 h to cisplatin at IC90 , 6h. A2780 human ovarian carcinoma cells NA
GSM198898
GPL8300
A2780_cis_IC90_6h_2 A2780 cells, exposed 2 h to cisplatin at IC90 , 6h. A2780 human ovarian carcinoma cells NA
GSM198899
GPL8300
A2780_cis_IC90_24h A2780 cells, exposed 2 h to cisplatin at IC90 , 24h. A2780 human ovarian carcinoma cells NA
GSM198900
GPL8300
A2780_oxa_IC90_0h_1 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 0h. A2780 human ovarian carcinoma cells NA
GSM198901
GPL8300
A2780_oxa_IC90_0h_2 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 0h. A2780 human ovarian carcinoma cells NA
GSM198902
GPL8300
A2780_oxa_IC90_2h_1 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 2h. A2780 human ovarian carcinoma cells NA
GSM198903
GPL8300
A2780_oxa_IC90_2h_2 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 2h. A2780 human ovarian carcinoma cells NA
GSM198904
GPL8300
A2780_oxa_IC90_6h_1 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 6h. A2780 human ovarian carcinoma cells NA
GSM198905
GPL8300
A2780_oxa_IC90_6h_2 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 6h. A2780 human ovarian carcinoma cells NA
GSM198906
GPL8300
A2780_oxa_IC90_24h A2780 cells, exposed 2 h to oxaliplatin at IC90 , 24h. A2780 human ovarian carcinoma cells NA
GSM198907
GPL8300
A2780_control_0h A2780 cells, control , 0h. A2780 human ovarian carcinoma cells NA
GSM198908
GPL8300
A2780_control_2h A2780 cells, control , 2h. A2780 human ovarian carcinoma cells NA
GSM198909
GPL8300
A2780_control_6h A2780 cells, control , 6h. A2780 human ovarian carcinoma cells NA
GSM198910
GPL8300
A2780_control_16h_1 A2780 cells, control , 16h. A2780 human ovarian carcinoma cells NA
GSM198911
GPL8300
A2780_control_16h_2 A2780 cells, control , 16h. A2780 human ovarian carcinoma cells NA
GSM198912
GPL8300
A2780_control_16h_3 A2780 cells, control , 16h. A2780 human ovarian carcinoma cells NA
GSM198913
GPL8300
A2780_control_16h_4 A2780 cells, control , 16h. A2780 human ovarian carcinoma cells NA
GSM198914
GPL8300
A2780_cis_IC10_16h_1 A2780 cells, exposed 2 h to cisplatin at IC10 , 16h. A2780 human ovarian carcinoma cells NA
GSM198915
GPL8300
A2780_cis_IC10_16h_2 A2780 cells, exposed 2 h to cisplatin at IC10 , 16h. A2780 human ovarian carcinoma cells NA
GSM198916
GPL8300
A2780_cis_IC25_16h_1 A2780 cells, exposed 2 h to cisplatin at IC25 , 16h. A2780 human ovarian carcinoma cells NA
GSM198917
GPL8300
A2780_cis_IC25_16h_2 A2780 cells, exposed 2 h to cisplatin at IC25 , 16h. A2780 human ovarian carcinoma cells NA
GSM198918
GPL8300
A2780_cis_IC50_16h_1 A2780 cells, exposed 2 h to cisplatin at IC50 , 16h. A2780 human ovarian carcinoma cells NA
GSM198919
GPL8300
A2780_cis_IC50_16h_2 A2780 cells, exposed 2 h to cisplatin at IC50 , 16h. A2780 human ovarian carcinoma cells NA
GSM198920
GPL8300
A2780_cis_IC75_16h_1 A2780 cells, exposed 2 h to cisplatin at IC75 , 16h. A2780 human ovarian carcinoma cells NA
GSM198921
GPL8300
A2780_cis_IC75_16h_2 A2780 cells, exposed 2 h to cisplatin at IC75 , 16h. A2780 human ovarian carcinoma cells NA
GSM198922
GPL8300
A2780_cis_IC90_16h_1 A2780 cells, exposed 2 h to cisplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198923
GPL8300
A2780_cis_IC90_16h_2 A2780 cells, exposed 2 h to cisplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198924
GPL8300
A2780_cis_IC90_16h_3 A2780 cells, exposed 2 h to cisplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198925
GPL8300
A2780_cis_IC90_16h_4 A2780 cells, exposed 2 h to cisplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198926
GPL8300
A2780_cis_IC90_16h_5 A2780 cells, exposed 2 h to cisplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198927
GPL8300
A2780_oxa_IC10_16h_1 A2780 cells, exposed 2 h to oxaliplatin at IC10 , 16h. A2780 human ovarian carcinoma cells NA
GSM198928
GPL8300
A2780_oxa_IC10_16h_2 A2780 cells, exposed 2 h to oxaliplatin at IC10 , 16h. A2780 human ovarian carcinoma cells NA
GSM198929
GPL8300
A2780_oxa_IC25_16h_1 A2780 cells, exposed 2 h to oxaliplatin at IC25 , 16h. A2780 human ovarian carcinoma cells NA
GSM198930
GPL8300
A2780_oxa_IC25_16h_2 A2780 cells, exposed 2 h to oxaliplatin at IC25 , 16h. A2780 human ovarian carcinoma cells NA
GSM198931
GPL8300
A2780_oxa_IC50_16h_1 A2780 cells, exposed 2 h to oxaliplatin at IC50 , 16h. A2780 human ovarian carcinoma cells NA
GSM198932
GPL8300
A2780_oxa_IC50_16h_2 A2780 cells, exposed 2 h to oxaliplatin at IC50 , 16h. A2780 human ovarian carcinoma cells NA
GSM198933
GPL8300
A2780_oxa_IC75_16h_1 A2780 cells, exposed 2 h to oxaliplatin at IC75 , 16h. A2780 human ovarian carcinoma cells NA
GSM198934
GPL8300
A2780_oxa_IC75_16h_2 A2780 cells, exposed 2 h to oxaliplatin at IC75 , 16h. A2780 human ovarian carcinoma cells NA
GSM198935
GPL8300
A2780_oxa_IC90_16h_1 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198936
GPL8300
A2780_oxa_IC90_16h_2 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198937
GPL8300
A2780_oxa_IC90_16h_3 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
GSM198938
GPL8300
A2780_oxa_IC90_16h_4 A2780 cells, exposed 2 h to oxaliplatin at IC90 , 16h. A2780 human ovarian carcinoma cells NA
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes